Compounds > beauvericin
Page last updated: 2024-08-26

beauvericin and Disease Models, Animal

beauvericin has been researched along with Disease Models, Animal in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Gu, YH; Ouyang, ZJ; Qian, C; Shen, Y; Sun, Y; Wu, XD; Wu, XF; Xu, Q; Xu, R1
An, R; Bian, J; Chen, X; Chen, Z; Dai, H; Fu, C; Gao, H; Goodfellow, M; Huang, R; Jiang, Y; Kuai, J; Liu, J; Liu, Z; Min, F; Pei, G; Song, Y; Sun, H; Sun, N; Wang, J; Yan, K; Yang, K; You, J; Yu, Z; Zhang, L; Zhang, S; Zhang, X; Zhang, Y; Zhao, W; Zheng, C; Zhou, G; Zhuo, Y1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1

Other Studies

3 other study(ies) available for beauvericin and Disease Models, Animal

ArticleYear
Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Animals; Apoptosis; Cell Proliferation; Colitis; Depsipeptides; Disease Models, Animal; Down-Regulation; Female; Flow Cytometry; Gene Expression Regulation, Enzymologic; Inflammation; Interferon-gamma; Lymphocyte Activation; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; T-Lymphocytes; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2013
High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Mar-13, Volume: 104, Issue:11

    Topics: Algorithms; Animals; Antifungal Agents; Cell Line; Depsipeptides; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Humans; Immunocompromised Host; Ketoconazole; Mice; Microbial Sensitivity Tests; Mycoses

2007
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020